FeesSafety
Pluang+

NWPX Infrastructure posts record Q3 sales of $179.4M and net income of $18.2M, driven by strong water systems demand.

Company Fundamentals
28 Oct 2026, 23:15 WIB
PRNewsWire
View Source
Bullish
NWPX Infrastructure posts record Q3 sales of $179.4M and net income of $18.2M, driven by strong water systems demand.

NWPX Infrastructure reported record third-quarter 2026 net sales of $179.4 million, an 18.7% increase year-over-year, and net income of $18.2 million, up 35%. The Water Transmission Systems segment led growth with a 27% sales increase and a backlog of $435 million including confirmed orders, signaling strong future demand. The Precast segment also showed modest sales growth and improved profitability. The company completed the acquisition of Serpentix Conveyor, expanding its product offerings. Despite seasonal and weather challenges expected in Q4, management anticipates continued strong performance and momentum into 2027.

NWPX Infrastructure's third-quarter 2026 financial results provide context for the Industrials sector on Pluang. As of Oct 29, 2026 02:41 WIB, out of 135 priced Industrials-sector US stocks, 54 rose and 80 fell. Among notable movers, FPS rose 6.97% to USD 28.87 with a Pluang order activity skewed 59% Sell / 41% Buy and a typical hold time of 4 days, contrasting with ODFL which dropped 6.88% to USD 174.43 but saw 100% Buy orders and a much longer hold time of 77 days. INIO also gained 6.36% to USD 18.06 but had 100% Sell orders and a very short hold time of 3 days.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
28 minutes ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
28 minutes ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
28 minutes ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
2 hours ago
Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology received a notification from Nasdaq on October 13, 2026, stating it failed to meet the minimum bid price requirement of $1.00 per share over the past 30 days. The company has 180 days, until April 12, 2027, to restore its share price ...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App